Latest Diabetes: Type II news
GLP-1 RAs, SGLT2 Inhibitors May Reduce Risk for Alzheimer Disease, Dementia in T2DM
posted April 17th
by modernClinician Editorial Team
by modernClinician Editorial Team
Certain Combinations of Food Additives May Increase Risk for Type 2 Diabetes
posted April 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Tirzepatide Dispensations Increased Rapidly After Approval
posted April 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
ACP: Switching From Dulaglutide to Tirzepatide Improves HbA1c Reduction in T2DM
posted April 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
2018 to 2025 Saw Sharp Rise in Postpartum GLP-1 Receptor Agonist Use .jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD 
Type 2 Diabetes Linked to Worse Menopausal Symptoms Monthly Specialist Briefings
Stay Connected
